Global cardiovascular needles is tend to have a CAGR of 6.50% in the forecast period of 2022-2029. This was valued at USD 84.4 million in 2021 and it is expected to rise up to 139.68 million by 2029. The global business landscape is undergoing a transformation, with industries increasingly leaning on deep research and actionable insights to make strategic decisions. One segment seeing...